NCT03872401: Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
- State
- Completed
- Phase
- Phase 3
- People
- 12,301 taking part
- Started
- 11 Jun 2019
- Primary completion
- 25 Jul 2025
- Arms
- Evolocumab 140 mg Q2W
- Results
- Posted on the registry
- 13 Mar 2019: Trial registered
- 11 Jun 2019: Trial started
- 25 Jul 2025: Trial completed
- 25 Jun 2026: Trial results posted